Available on-demand. Login or create an account to register to view the recording.

This course was originally offered as part of "ORN - Hot Topics in Addiction Medicine - Spring 2022 Webinar Series (On-Demand)" course. If you took or registered for that course, you will not be able to access this course.

At the conclusion of this webinar, attendees will be able to:

• Understand different types of stigma and how they apply in the context of substance use disorder
• Gain insights into how drug-related stigma is perceived, experienced, and manifested by people who use drugs in the context of health services
• Identify approaches for mitigating stigma in health settings

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):

1. Complete the required course materials.
2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.

This webinar has been approved for a maximum 1, AOA Category 1-A CME credits, and AOA designates this for a maximum of 1, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.

Robin Pollini, PhD, MPH Dr. Pollini is a substance use and infectious disease epidemiologist whose research focuses on mitigating the adverse health impacts of injection drug use; these include overdose, HIV, viral hepatitis, and serious injection-related bacterial infections like endocarditis. She uses innovative mixed methods study designs to examine how individual- and structural-level factors influence drug-related morbidity and mortality as well as health services access and utilization among people who inject drugs. Dr. Pollini has been Principal Investigator of several grants funded by the National Institute on Drug Abuse (NIDA).